Details for New Drug Application (NDA): 021947
✉ Email this page to a colleague
The generic ingredient in FENTORA is fentanyl citrate. There are thirty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fentanyl citrate profile page.
Summary for 021947
| Tradename: | FENTORA |
| Applicant: | Cephalon |
| Ingredient: | fentanyl citrate |
| Patents: | 2 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;BUCCAL, SUBLINGUAL | Strength | EQ 0.1MG BASE | ||||
| Approval Date: | Sep 25, 2006 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Start Trial | Patent Expiration: | Jun 15, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | ⤷ Start Trial | Patent Expiration: | Jun 15, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;BUCCAL, SUBLINGUAL | Strength | EQ 0.2MG BASE | ||||
| Approval Date: | Sep 25, 2006 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Start Trial | Patent Expiration: | Jun 15, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Expired US Patents for NDA 021947
Complete Access Available with Subscription
